Concepedia

Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors

Narek Shaverdian, Jason Beattie, Maria Thor, Michael Offin, Annemarie F. Shepherd, Daphna Y. Gelblum, Abraham J. Wu, Charles B. Simone, Matthew D. Hellmann, Jamie E. Chaft,

Annals of Oncology · 2020 · 52 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson, Stephen Harrow et al. · Journal of Clinical Oncology · 2020 · 1.2K citations · Full text

, , +17

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian, Aaron Lisberg, Krikor Bornazyan et al. · The Lancet Oncology · 2017 · 1.1K citations

, , +17

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 984 citations · Full text

, , +17

CERR: A computational environment for radiotherapy research

Joseph O. Deasy, Angel I. Blanco, V Clark · Medical Physics · 2003 · 876 citations

, , +17

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Charles Dolladille, Stéphane Éderhy, Marion Sassier et al. · JAMA Oncology · 2020 · 582 citations · Full text

, , +17